Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  04:00 2022-11-29 pm EST
281.99 USD   -0.22%
11/29Sanofi in Early Deal Talks with Horizon Therapeutics
MT
11/29Stocks to Watch: Horizon Therapeutics, Workday, NetApp, Crowdstrike, Wayfair
DJ
11/29Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Transcript : Amgen Inc. Presents at BofA Securities Global Healthcare Conference 2022, Sep-15-2022 08:55 AM

09/15/2022 | 04:55am EST
Excellent. Welcome to the BofA London Healthcare Conference. So my name is Geoff Meacham I'm in a senior biopharma analyst here at BofA. And we're thrilled to have Amgen with us and up here on stage...


ę S&P Capital IQ 2022
All news about AMGEN INC.
11/29Sanofi in Early Deal Talks with Horizon Therapeutics
MT
11/29Stocks to Watch: Horizon Therapeutics, Workday, NetApp, Crowdstrike, Wayfair
DJ
11/29Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
RE
11/29Horizon Therapeutics Confirms 'Highly Preliminary Discussions' With Three Suitors -- Sh..
MT
11/29Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
RE
11/29Transcript : Amgen Inc. Presents at 5th Annual Evercore ISI HealthCONx Confer..
CI
11/28Amgen to webcast investor call at wcirdc 2022
PR
11/24U.S. Supreme Court To Decide On Enablement Standard For Biotech Antibody Patents In Amg..
AQ
11/23Amgen announces webcast of 2022 evercore isi healthcare conference
PR
11/22Amneal Pharmaceuticals Launches Releuko for Neutropenia in US
MT
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Financials (USD)
Sales 2022 26 240 M - -
Net income 2022 6 539 M - -
Net Debt 2022 26 379 M - -
P/E ratio 2022 23,3x
Yield 2022 2,73%
Capitalization 150 B 150 B -
EV / Sales 2022 6,74x
EV / Sales 2023 6,42x
Nbr of Employees 24 200
Free-Float 99,8%
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Last Close Price 281,99 $
Average target price 260,71 $
Spread / Average Target -7,54%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Senior VP-Translational Sciences & Oncology
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.25.63%150 464
JOHNSON & JOHNSON2.93%463 626
ELI LILLY AND COMPANY32.42%347 547
ABBVIE INC.16.84%280 085
PFIZER, INC.-16.19%278 252
MERCK & CO., INC.42.01%274 964